Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1
Augusta University · NCT04449198
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 24
- US sites recruiting
- 1
- Study start
- October 14, 2020
- Record last updated
- January 28, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The proposed study is designed to test the hypothesis that treatment of resveratrol for 12 weeks will improve both endothelin-B receptor (aim 1) and skeletal muscle mitochondrial function (aim 2) in people with type 1 diabetes.
Being studied: Resveratrol; Placebo
Conditions: Type 1 Diabetes
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Men and premenopausal women
- All races
- Clinical diagnosis of insulin-dependent type 1 diabetes (patients only)
Exclusion Criteria
- Clinical diagnosis of hepatic, cardiovascular, or renal disease
- Uncontrolled diabetes (HbA1C >12%)
- Diabetic complications (i.e. neuropathy)
- Uncontrolled hypertension (>140/90 mm Hg on therapy)
- Pregnancy
- Use of vasoactive medications
Recruiting US locations
Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology
Augusta, GA 30912
Site contact: Ryan Harris, PhD, CEP · 706-721-5998 · ryharris@augusta.edu
Study contacts (from the official record)
- Ryan A Harris, PhD, CEP · 7067215998 · ryharris@augusta.edu
- Jacob Looney, MS · 7067215483 · jlooney@augusta.edu
Similar studies in Georgia
All diabetes studies in Georgia →- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Atlanta, GA + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Augusta, GA + 121 other US sites
- Eligibility basics
- Ages 55+
- Recruiting
SPYRAL GEMINI Pilot Study
Medtronic Vascular
- Location
- Atlanta, GA + 11 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Biomea Fusion Inc.
- Location
- Columbus, GA + 19 other US sites
- Eligibility basics
- Ages 18–75